Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $15,870 | $14,303 | $14,020 | $31,701 |
| - Cash | $25,451 | $34,068 | $41,789 | $44,664 |
| + Debt | $1,666 | $2,023 | $2,368 | $2,707 |
| Enterprise Value | -$7,915 | -$17,742 | -$25,401 | -$10,256 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$357 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,281 | -$9,464 | -$11,376 | -$13,762 |
| % Margin | – | – | – | – |
| Net Income | -$6,936 | -$9,802 | $10,220 | -$13,844 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.42 | -2.01 | 1.79 | -3.53 |
| % Growth | 29.4% | -212.3% | 150.7% | – |
| Operating Cash Flow | -$8,598 | -$7,736 | -$11,264 | -$16,010 |
| Capital Expenditures | -$23 | $0 | -$110 | $0 |
| Free Cash Flow | -$8,621 | -$7,736 | -$11,374 | -$16,010 |